Suchergebnisse - "Gyawali, Bishal"

PubPharm (308)

71

Cancer Groundshot : Building a Robust Cancer Control Platform in Addition To Launching the Cancer Moonshot

enthalten in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting | 2022

von Mutebi, M. | Dehar, N. | Nogueira, L. | +3

72

Cancer treatments should benefit patients : a common-sense revolution in oncology

enthalten in: Nature medicine | 2022

von Gyawali, B. | Booth, C.

73

Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers : An Overview of Global Research Activity

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Wells, J. | Fundytus, A. | Sharma, S. | +9

74

Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer

enthalten in: JAMA network open | 2022

von Li, X. | Beeghly-Fadiel, A. | Bhavnani, S. | +6

CommentIn: JAMA Netw Open. 2022 Apr 1;5(4):e224380. - PMID 35416996

75

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs

enthalten in: Lancet regional health. Americas | 2022

von Gyawali, B. | Carson, L. | Berry, S. | +1

76

Progression-free survival : it is time for a new name

enthalten in: The Lancet. Oncology | 2022

von Gyawali, B. | Eisenhauer, E. | Tregear, M. | +1

77

Use of imaging for active surveillance in testicular cancer : Is real-world practice concordant with guidelines?

enthalten in: Canadian Urological Association journal = Journal de l'Association des urologues du Canada | 2022

von Gyawali, B. | Griffiths, R. | Robinson, A. | +3

CommentIn: J Urol. 2022 Oct;208(4):934-935. - PMID 35917468

78

Global consequences of the US FDA's accelerated approval of cancer drugs

enthalten in: The Lancet. Oncology | 2022

von Akhade, A. | Sirohi, B. | Gyawali, B.

CommentIn: Lancet Oncol. 2022 Apr;23(4):e160. - PMID 35358460

79

Trends in drug revenue among major pharmaceutical companies : A 2010-2019 cohort study

enthalten in: Cancer | 2022

von Meyers, D. | Meyers, B. | Chisamore, T. | +5

80

Radiographic progression-free survival in the ACIS trial for prostate cancer

enthalten in: The Lancet. Oncology | 2022

von Tannock, I. | Booth, C. | Gyawali, B. | +1

CommentOn: Lancet Oncol. 2021 Nov;22(11):1541-1559. - PMID 34600602